Primary and Secondary Long-Term Prophylaxis of Thromboembolism in Outpatients with the Low-Molecular-Weight Heparin Kabi 2165

التفاصيل البيبلوغرافية
العنوان: Primary and Secondary Long-Term Prophylaxis of Thromboembolism in Outpatients with the Low-Molecular-Weight Heparin Kabi 2165
المؤلفون: Harenberg, J., Leber, G., Raedsch, R., Zimmermann, R., Schwarz, F., Kübler, W.
المصدر: Haemostasis; January 1988, Vol. 18 Issue: 1 p78-81, 4p
مستخلص: Bleeding episodes and other side effects may complicate the treatment with oral anticoagulants. We report on the results of 66 patients who were treated with a low molecular weight heparin fraction for up to 19 months. The data of the study demonstrate the effective long-term anticoagulation with low-molecular-weight heparin and the reduced incidence of hemorrhages compared with conventional anticoagulants. Thus, low-molecular-weight heparin may be effectively and safely used for long-term anticoagulation in patients with bleeding problems on conventional anticoagulants.
قاعدة البيانات: Supplemental Index